Mg0003 50089 — Philadelphia, Pennsylvania

Mg0003 50089 is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0003 50089 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0003 50089?

Mg0003 50089 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0003 50089 conducted?

Mg0003 50089 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Mg0003 50089 accredited by Crixeo Health?

Mg0003 50089 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0003 50089?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.